This site is intended for healthcare professionals
News

CHMP recommends approval of Enspryng for neuromyelitis optica spectrum disorder.- Roche

Read time: 1 mins
Last updated:28th Jun 2021
Published:25th Apr 2021
Condition: Neuromyelitis Optica
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest